awards grant CoVPN 3001: Phase 3, SARS-CoV-2 Vaccine (Moderna TX, Inc.) CoVPN 3004: Phase 3, SARS-CoV-2 Vaccine (Novavax) HIV Prevention Trials Network (HPTN 083 - NJMS) HIV Prevention Trials Network (HPTN 083 FHI360 - WCM) HIV Prevention Trials Network (HPTN 083 FHI360 - WCM) HPTN 083 - Viiv Funding
